preterm severity-stratified metabolic screening
Related entities
Findings (27)
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86